McGillicuddy John W, Chambers Sean D, Galligan Darren T, Hirschl Ronald B, Bartlett Robert H, Cook Keith E
Department of Surgery, University of Michigan, Ann Arbor, MI, USA.
ASAIO J. 2005 Nov-Dec;51(6):789-94. doi: 10.1097/01.mat.0000182473.47668.f1.
This in vitro study sought to determine what compliance minimizes thoracic artificial lung impedance and pump power output. A pulsatile pump drove 3.0 cP glycerol through a circuit consisting of an MC3 Biolung preceded by a piston-cylinder (PC, n = 5) chamber with a variable compliance or a polyurethane (n = 4) chamber with a fixed, yet pressure-dependent, compliance. Each chamber was tested at flow rates of 1.8, 3.0, and 5.0 l/min and heart rates of 60, 75, and 100 bpm. Compliances, C, from 0-20 ml/mm Hg were tested in the PC chamber. Instantaneous pump outlet flow and pressure were acquired for determination of device zeroth and first harmonic input impedance, Z(0) and Z(1), and pump steady and pulsatile output powers, P(s) and P(p). PC chamber results indicate that Z(0), Z(1), P(s), and Pp were minimized at C > 1, 5, 0.5, and 4 ml/mm Hg, respectively. This suggests that C should be 1 ml/mm Hg at minimum and ideally 5 ml/mm Hg. The polyurethane chamber was statistically similar to the PC chamber at C = 1 ml/mm Hg when comparing Z(0) and P(s), but was statistically inferior when comparing Z(1) and P(p). The polyurethane compliance chamber, therefore, should be redesigned with greater compliance.
这项体外研究旨在确定何种顺应性可使胸段人工肺的阻抗和泵的功率输出最小化。一个搏动泵驱动3.0厘泊的甘油通过一个回路,该回路由一个MC3生物肺以及一个前置的活塞 - 气缸(PC,n = 5)腔室或一个具有固定但与压力相关顺应性的聚氨酯(n = 4)腔室组成。每个腔室在流速为1.8、3.0和5.0升/分钟以及心率为60、75和100次/分钟的条件下进行测试。在PC腔室中测试了0至20毫升/毫米汞柱的顺应性(C)。采集了泵的瞬时出口流量和压力,以确定设备的零阶和一阶谐波输入阻抗Z(0)和Z(1),以及泵的稳定和搏动输出功率P(s)和P(p)。PC腔室的结果表明,Z(0)、Z(1)、P(s)和P(p)分别在C > 1、5、0.5和4毫升/毫米汞柱时最小化。这表明C至少应为1毫升/毫米汞柱,理想情况下为5毫升/毫米汞柱。在比较Z(0)和P(s)时,聚氨酯腔室在C = 1毫升/毫米汞柱时与PC腔室在统计学上相似,但在比较Z(1)和P(p)时在统计学上较差。因此,聚氨酯顺应性腔室应重新设计以具有更大的顺应性。